BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7521860)

  • 1. Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.
    Maier R; Falk K; Rötzschke O; Maier B; Gnau V; Stevanović S; Jung G; Rammensee HG; Meyerhans A
    Immunogenetics; 1994; 40(4):306-8. PubMed ID: 7521860
    [No Abstract]   [Full Text] [Related]  

  • 2. Abrogation of H-2-restricted CTL responses and efficient recognition of HLA-A3 molecules in DBA/2 HLA/A24 responder mice.
    Barra C; Gournier H; Garcia Z; Marche PN; Jouvin-Marche E; Briand P; Fillipi P; Lemonnier FA
    J Immunol; 1993 May; 150(9):3681-9. PubMed ID: 7682582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.
    Bakker AH; Hoppes R; Linnemann C; Toebes M; Rodenko B; Berkers CR; Hadrup SR; van Esch WJ; Heemskerk MH; Ovaa H; Schumacher TN
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3825-30. PubMed ID: 18308940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.
    Sidney J; Southwood S; Sette A
    Immunogenetics; 2005 Jul; 57(6):393-408. PubMed ID: 16003466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.
    Lim WC; Khan AM
    BMC Genomics; 2018 Jan; 19(Suppl 1):42. PubMed ID: 29363421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of specific peptide motifs for four major HLA-A alleles.
    Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
    J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis.
    Reynolds SR; Celis E; Sette A; Oratz R; Shapiro RL; Johnston D; Fotino M; Bystryn JC
    J Immunol Methods; 2000 Oct; 244(1-2):59-67. PubMed ID: 11033019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
    Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
    J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cytotoxic human-human hybridoma antibodies to HLA: TrAH10 (anti A3.1) and TrAG2 (anti B7, Bw42).
    Hansen T; Bratlie A; Johansen B; Hannestad K
    Tissue Antigens; 1989 May; 33(5):520-30. PubMed ID: 2552610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of gp100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells.
    Kawashima I; Tsai V; Southwood S; Takesako K; Celis E; Sette A
    Int J Cancer; 1998 Nov; 78(4):518-24. PubMed ID: 9797143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of peptide epitopes of MAGE-1, -2, -3 that demonstrate HLA-A3-specific binding.
    McIntyre CA; Rees RC; Platts KE; Cooke CJ; Smith MO; Mulcahy KA; Murray AK
    Cancer Immunol Immunother; 1996 May; 42(4):246-50. PubMed ID: 8665572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding.
    Engelhard VH; Appella E; Benjamin DC; Bodnar WM; Cox AL; Chen Y; Henderson RA; Huczko EL; Michel H; Sakaguichi K
    Chem Immunol; 1993; 57():39-62. PubMed ID: 8260089
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of HLA-B7 T-cell epitopes.
    Freese A; Zavazava N
    Transpl Int; 1996; 9 Suppl 1():S352-5. PubMed ID: 8959863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling.
    Huczko EL; Bodnar WM; Benjamin D; Sakaguchi K; Zhu NZ; Shabanowitz J; Henderson RA; Appella E; Hunt DF; Engelhard VH
    J Immunol; 1993 Sep; 151(5):2572-87. PubMed ID: 8360479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
    J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.
    Matsueda S; Takedatsu H; Yao A; Tanaka M; Noguchi M; Itoh K; Harada M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6933-43. PubMed ID: 16203785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.